EUVIMEDEUVIMED entdecken
Crossref

Cascade‐Targeted Type I/II Sensitizer Enabled by Enzyme‐Instructed Self‐Assembly for Amplified Sono‐Photodynamic Tumor Therapy

Jinling Zheng, Yingying Ke, Dandan Meng, Marie Helene Delville, Shiwen Yu, Yiteng Huang, Xiaoyu Xu, Xu Zhang, Shayibai Shabiti, Na Liang, Yujue Wang, Fangjie Li und 2 weitere

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202505712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Jinling Zheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Key Laboratory of Nanomedicine, Shenzhen Engineering Laboratory of Nanomedicine and Nanoformulations, CAS-HK Joint Lab For Biomaterials, CA…. Hauptthemen laut MEDLINE: Photochemotherapy, Photosensitizing Agents, Ultrasonic Therapy, Neoplasms. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Hunan Students' Platform for innovation and entrepreneurship training program, Shenzhen Science and Technology Program, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sono‐photodynamic therapy (SPDT) offers a non‐invasive, spatiotemporally precise approach to cancer treatment, but its effectiveness is still limited by poor tumor specificity and penetration. To address this, we developed a cascade‐targeted type I/II sensitizer, Ce6‐TPP‐Phe‐Tyr (CTPT), which integrates chlorin e6 (Ce6), triphenylphosphonium (TPP), and a phospho‐peptide motif for precise tumor targeting and potent SPDT. Upon dephosphorylation by tumor‐overexpressed alkaline phosphatase (ALP), CTPT undergoes enzyme‐instructed self‐assembly (EISA) into nanoparticles (CTPT NPs), promoting their accumulation and retention in tumors. The TPP cations then guide these nanoparticles to mitochondria, concentrating the therapeutic payload at this critical organelle for cellular energy metabolism. Subsequent ultrasound/laser irradiation further enhances tissue permeability and triggers the generation of both type I and type II reactive oxygen species (ROS), leading to potent oxidative damage. This integrated strategy of EISA and mitochondria‐targeted SPDT achieved approximately 86% tumor regression in ALP‐overexpressing xenografts. This strategy minimizes systemic toxicity and achieves potent tumor regression by cascade delivery of the therapeutic agent, thereby significantly enhancing the precision and efficacy of SPDT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyPhotosensitizing AgentsUltrasonic TherapyNeoplasmsAnimalsHumansPorphyrinsChlorophyllidesCell Line, TumorNanoparticlesMiceAlkaline PhosphataseMitochondriaReactive Oxygen SpeciesMice, Nude

Stichwörter der Autor:innen

ALPenzyme‐instructed self‐assembly (EISA)sensitizersono‐photodynamic therapy (SPDT)tumor‐targeting

Substanzen

Photosensitizing AgentsPorphyrinsChlorophyllidesphytochlorinAlkaline PhosphataseReactive Oxygen Species

Autor:innen und Institutionen

  • Guangdong Key Laboratory of Nanomedicine, Shenzhen Engineering Laboratory of Nanomedicine and Nanoformulations, CAS-HK Joint Lab For Biomaterials, CAS Key Lab For Health Informatics, Institute of Biomedicine and Biotech…
  • University of Chinese Academy of Sciences, Beijing, P. R. China.
  • Institute of Biopharmaceutical and Health Engineering (iBHE), Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, P. R. China.
  • Univ. Bordeaux, CNRS, Bordeaux INP, ICMCB, UMR 5026, Pessac, France.
  • China Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research [Hunan Provincial Science and Technology Department Document (Approval number: 2019-56)], School of Pharmaceutical Science, Univer…
  • Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, Hunan, P. R. China.

ORCID-Profile: Hongfei Chen, Wenjun Li

Förderung

  • Hunan Students' Platform for innovation and entrepreneurship training program
  • Shenzhen Science and Technology Program
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Shenzhen Science and Technology Innovation Program

Zitieren

APA

Zheng, J., Ke, Y., Meng, D., Delville, M. H., Yu, S., Huang, Y., Xu, X., Zhang, X., Shabiti, S., Liang, N., Wang, Y., Li, F., Chen, H., & Li, W. (2026). Cascade‐Targeted Type I/II Sensitizer Enabled by Enzyme‐Instructed Self‐Assembly for Amplified Sono‐Photodynamic Tumor Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202505712

Vancouver

Zheng J, Ke Y, Meng D, Delville MH, Yu S, Huang Y, et al. Cascade‐Targeted Type I/II Sensitizer Enabled by Enzyme‐Instructed Self‐Assembly for Amplified Sono‐Photodynamic Tumor Therapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202505712

BibTeX
@article{Zheng2026,
  author = {Zheng, Jinling and Ke, Yingying and Meng, Dandan and Delville, Marie Helene and Yu, Shiwen and Huang, Yiteng and Xu, Xiaoyu and Zhang, Xu and Shabiti, Shayibai and Liang, Na and Wang, Yujue and Li, Fangjie and Chen, Hongfei and Li, Wenjun},
  title = {Cascade‐Targeted Type I/II Sensitizer Enabled by Enzyme‐Instructed Self‐Assembly for Amplified Sono‐Photodynamic Tumor Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202505712}
}
Kostenlos starten →